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ABSTRACT: Most small-molecule drug candidates fail before
entering the market, frequently because of unexpected toxicity.
Often, toxicity is detected only late in drug development, because
many types of toxicities, especially idiosyncratic adverse drug
reactions (IADRs), are particularly hard to predict and detect.
Moreover, drug-induced liver injury (DILI) is the most frequent
reason drugs are withdrawn from the market and causes 50% of
acute liver failure cases in the United States. A common mechanism
often underlies many types of drug toxicities, including both DILI
and IADRs. Drugs are bioactivated by drug-metabolizing enzymes
into reactive metabolites, which then conjugate to sites in proteins or DNA to form adducts. DNA adducts are often mutagenic
and may alter the reading and copying of genes and their regulatory elements, causing gene dysregulation and even triggering
cancer. Similarly, protein adducts can disrupt their normal biological functions and induce harmful immune responses.
Unfortunately, reactive metabolites are not reliably detected by experiments, and it is also expensive to test drug candidates for
potential to form DNA or protein adducts during the early stages of drug development. In contrast, computational methods have
the potential to quickly screen for covalent binding potential, thereby ﬂagging problematic molecules and reducing the total
number of necessary experiments. Here, we train a deep convolution neural networkthe XenoSite reactivity modelusing
literature data to accurately predict both sites and probability of reactivity for molecules with glutathione, cyanide, protein, and
DNA. On the site level, cross-validated predictions had area under the curve (AUC) performances of 89.8% for DNA and 94.4%
for protein. Furthermore, the model separated molecules electrophilically reactive with DNA and protein from nonreactive
molecules with cross-validated AUC performances of 78.7% and 79.8%, respectively. On both the site- and molecule-level, the
model’s performances signiﬁcantly outperformed reactivity indices derived from quantum simulations that are reported in the
literature. Moreover, we developed and applied a selectivity score to assess preferential reactions with the macromolecules as
opposed to the common screening traps. For the entire data set of 2803 molecules, this approach yielded totals of 257 (9.2%)
and 227 (8.1%) molecules predicted to be reactive only with DNA and protein, respectively, and hence those that would be
missed by standard reactivity screening experiments. Site of reactivity data is an underutilized resource that can be used to not
only predict if molecules are reactive, but also show where they might be modiﬁed to reduce toxicity while retaining eﬃcacy. The
XenoSite reactivity model is available at http://swami.wustl.edu/xenosite/p/reactivity.
■ INTRODUCTION
Most small-molecule drug candidates fail before entering the
market,1 frequently because of unexpected toxicity.1,2 Often,
toxicity is detected only late in drug development, because
many types of toxicities, especially idiosyncratic adverse drug
reactions (IADRs), are particularly hard to predict and
detect.3,4 Moreover, drug-induced liver injury (DILI) is the
most frequent reason drugs are withdrawn from the market and
causes 50% of acute liver failure cases in the United States.5
A common mechanism often underlies many types of drug
toxicity, including both DILI and IADRs. Drugs are
bioactivated by drug-metabolizing enzymes into reactive
metabolites, which then conjugate to sites in proteins or
DNA to form adducts. DNA adducts are often mutagenic and
may alter the reading and copying of genes and their regulatory
elements, causing gene dysregulation and even triggering
cancer.5−7 Similarly, protein adducts can disrupt their normal
biological functions and induce harmful immune responses.5,8,9
Metabolites are reactive because of their chemical properties
and are often generally classiﬁed as soft or hard electrophiles
based on polarizability and their preferential reaction with
targeted nucleophiles.10 Soft electrophiles such as epoxides or
Michael acceptors have low electron density at multiple sites,
while hard electrophiles such as carbocations or saturated
aldehydes have a localized site with low electron density.10−12
Received: June 3, 2016
Published: July 29, 2016
Research Article
http://pubs.acs.org/journal/acscii
© 2016 American Chemical Society 529 DOI: 10.1021/acscentsci.6b00162
ACS Cent. Sci. 2016, 2, 529−537
This is an open access article published under an ACS AuthorChoice License, which permits
copying and redistribution of the article or any adaptations for non-commercial purposes.
Soft electrophiles tend to react with soft nucleophiles, such as
cysteine residues within glutathione (GSH) or protein, whereas
hard electrophiles generally react with hard nucleophiles, such
as purine and pyrimidine bases in DNA or lysine and histidine
residues within protein.5,10,11,13−15 Despite these general rules,
it remains a challenge to predict the reactivity of small
molecules and their likelihood for modifying DNA and
proteins.
Conjugation between small molecules and nucleophilic GSH
(soft) or cyanide (hard) is commonly used in screening studies
to identify molecules capable of forming adducts. Detecting
GSH or cyanide adducts is easier than detecting protein or
DNA adducts, and serves as a proxy for reactivity to
macromolecules in experimental studies.16,17 Moreover, GSH
is a physiologically relevant trapping agent, which reaches
millimolar levels in cells and protectively conjugates with many
reactive molecules.18
However, GSH and cyanide are only imperfect proxies for
protein and DNA. Proteins and DNA are structurally complex
macromolecules and likely have correspondingly complex
reactivities with a diverse set of soft and hard nucleophilic
sites. Therefore, we expect some molecules will react with
protein or DNA, but not eﬃciently react with GSH or cyanide.
These molecules are of special concern, because they do not
react with GSH or cyanide, and consequently are likely to be
missed by many standard reactivity experiments. Computa-
tional modeling could provide a complementary strategy for
detecting molecules likely to be reactive, and therefore prone to
causing DILI or IADRs, including those molecules missed by
standard screening assays. Others have proposed QSAR models
to predict GSH reactivity, yet these models are of limited value,
as they are focused on very limited structural groups.19 In
contrast, we recently published a computational model that
predicted GSH reactivity toward a diverse set of chemicals at
both the site and molecule level.20
Here, we extended our previously published GSH reactivity
model to also predict reactivity with cyanide, protein, and
DNA. First, we extracted a structurally diverse, literature-
derived database of molecules known to bind DNA and
protein, as well as the simple nucleophilic traps cyanide and
GSH (Figure 1). Second, we labeled the site of conjugation on
each molecule, known as its site of reactivity (SOR). Third, we
used a deep convolution neural network to accurately predict
these SORs in cross-validated experiments. Fourth, we
transformed SOR scores to accurate molecule-level electro-
philic reactivity scores that accurately predict whether
molecules will conjugate to DNA or protein. Fifth, we applied
these molecule reactivity scores to calculate DNA and protein
selectivity scores to estimate the fraction of molecules that are
reactive to DNA and protein but not cyanide or GSH.
Figure 1. Examples of the four types of sites of electrophilic reactivity modeled. Predictions by the XenoSite reactivity model are indicated on the left
with a colored shading gradient and white circle for each known site of reactivity. These predictions range from zero to one, indicating the probability
that an atom is reactive with each of the four nucleophilic targets. From top to bottom, a cyanide conjugation of a nefazodone metabolite,21 a DNA
conjugation of N-acetylbenzidine,22 a glutathione (GSH) conjugation of menadione,23 and a protein conjugation of a butylated hydroxytoluene
metabolite.24 DNA and protein are inherently structurally diverse, and thus cartoonized macromolecules are depicted, with the rest of each
macromolecule represented by “Xx”.
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Of course, ultimately, the XenoSite reactivity model will be
connected to models of drug metabolism to be most useful.
Although out of the scope of this study, combined metabolism
and reactivity models would be able to predict both
bioactivation and subsequent toxicity of metabolites. Nonethe-
less, this study takes a signiﬁcant step toward eﬀectively
managing the IADR and DILI risk of new medications with
computational modeling.
■ RESULTS AND DISCUSSION
In the initial section, we summarize a systematic eﬀort to
optimize the structure and training of the model, with the goal
of choosing the best method for predicting reactivity. The
following sections then investigate the performance of the ﬁnal
optimized model. First, we evaluated the model’s cross-
validated atom reactivity scores (ARS) by testing SOR
classiﬁcation performance within reactive molecules. Second,
we compared ARS performance to that of atom-level quantum
chemical reactivity indices. Third, we assessed ARS perform-
ance on an external test set. Fourth, we calculated the accuracy
of the model’s cross-validated molecule reactivity scores (MRS)
at predicting molecule reactivity. Fifth, we compared MRS
performance to molecule-level quantum chemical reactivity
indices. Sixth, we use the model to estimate the number of high
throughput screening molecules that are reactive with macro-
molecules (DNA and protein) but are not ﬂagged by small-
molecule trapping agents (GSH and cyanide).
Model Optimization. Several experiments demonstrate
how each of the innovations in our modeling approach
improves performance. These experiments are brieﬂy discussed
here, and further details and data are available in Supporting
Information. First, we hypothesized that jointly modeling
several types of reactivity in a multitask learning model would
improve predictions on the smaller data sets.25,26 Indeed, the
multitask model outperformed the individual modeling
approach at predicting cyanide and protein SOR (Figure S2).
This is likely because the cyanide and protein reactivity tasks
are the most diﬃcult and, therefore, beneﬁt most from
integrated modeling. The cyanide data set is diﬃcult because
it is small, and the protein data set is both small and includes
the most diverse mechanisms. The data reported herein reﬂects
modeling all four types of reactivity together in a multitask
network, instead of building separate models for each task.
Second, a modular input layer was used to group related
descriptors (such as the identities of all atoms a certain depth
away), rather than a traditional three-layer neural network
structure. We hypothesized that building explicit chemical
knowledge into the model structure could reduce the total
number of parameters in the model, thereby creating a simpler
model with better generalizability. This possibility was inspired
by several examples of modular neural networks in the
literature.27−32 In fact, the modular structure did enable
reduction of the total number of weights in the model by
50%, while retaining the same performance (Figure S3). This
weight-reduced, modularly structured model outperformed a
traditionally structured model with the same number of
weights. Third, we found that including quantum chemical
descriptors did not improve performance compared to a
topological-descriptor-only model (Figure S4), so we did not
include the quantum chemical descriptors in the ﬁnal model.
Construction of this topological-descriptor-only model was
inspired by our previous model of GSH reactivity, which
primarily relied upon topological descriptors rather than
quantum chemical descriptors.20 A common critique of neural
networks is their opacity compared to more transparent
methods with easily interpretable weights, like a logistic
regressor. In response to this critique and to gain insight into
the inner workings of our model, a permutation sensitivity
analysis was performed (Figure S5). We have previously used
this approach to expose the structure of similar models.20,33,34
Figure 2. Atom reactivity scores (ARS) accurately identiﬁed sites of reactivity (SORs). The average site AUC (top left) and top-two (top center)
metrics were computed for each of the four target nucleophiles and used to assess the cross-validated ARS for 1364 reactive molecules extracted from
the Accelrys Metabolite Database (AMD) with their SORs labeled. ARS outperformed all quantum chemical descriptors tested for each target
nucleophile. Bottom, from the latest AMD release, an external test of 14 molecules was extracted and SOR(s) labeled for GSH. Performance is
equivalent to that of the cross-validated predictions as measured by both the average site AUC (bottom left) and the top-two (bottom center)
metrics. Right, two example molecules from the external test set are visualized with their predictions, indicated by the colored shading. Each site of
reactivity is labeled with a white circle. Top right, an antimalarial drug candidate metabolite,44 and bottom right, geﬁtinib.45
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Details of the permutation sensitivity analysis are available in
the Supporting Information. Fourth and ﬁnally, we found that
including the negative epoxides in the training data substantially
improved the model’s ability to identify reactive epoxides
(Figure S6).
Accuracy at Predicting Sites of Reactivity. A central
objective of this study was to accurately predict SORs: the
speciﬁc atom(s) within reactive molecules that covalently bind
to nucleophilic sites within DNA and protein. The XenoSite
reactivity model gives four reactivity scores to each atom (ARS)
within a test molecule, each of which ranged from zero to one,
and represented the probability that an atom is reactive with
cyanide, DNA, GSH, or protein, respectively. Within a reactive
molecule, a well-performing model should assign reactive atoms
with higher scores than nonreactive atoms. The magnitude of
the SOR values and identity of the target(s) of the reactive
molecule sheds light on preferential chemistries leading to
adduction and structures of the adducts. Such knowledge is
relevant for reactive metabolite identiﬁcation under exper-
imental conditions and further study on the consequences of
adducts on normal biological processes. Furthermore, SOR
predictions indicate the probability of reactive hot spots leading
to unfavorable adductions, and such knowledge could be
leveraged to engineer rational modiﬁcations to reduce a
molecule’s reactivity and potentially its toxicity.
The accuracy of the ARS scores was assessed using 10
replicates of 10-fold cross-validation, where groups of related
molecules are held out in the same fold. Each replicate yielded
very similar results, so for brevity we reported the results from
the ﬁrst one. Performance was quantiﬁed by two metrics. First,
we calculated the average site area under the curve (AUC) by
computing the area under the receiver operating characteristic
(ROC) curve (AUC) for each molecule and averaging the
AUCs for each molecule in the data set.20,34 Second, we
calculated the top-two metric, which is a standard for site of
metabolism predictions. This approach considers a molecule
correctly predicted if any of its SOR are predicted in the ﬁrst or
second rank positions.34−38 Reactivity indices drawn from the
quantum modeling literature are another method for predicting
atom reactivity,39−43 and thus, they provide an important point
of comparison to our ARS for predicting SOR.
XenoSite’s cross-validated ARS predicted reactive atoms with
average site AUC accuracies of 96.6%, 89.8%, 92.8%, and
94.4%, and top-two accuracies of 83.9%, 80.6%, 80.9%, and
84.2%, for cyanide, DNA, GSH, and protein, respectively
(Figure 2). These performances are very accurate, especially
when compared to the current standard of atom-level reactivity
indices (listed in Table 1) from quantum simulations.39−43
Consistent with our previous model of GSH reactivity, ARS
outperformed all reactivity indices tested across all four
nucleophilic targets.20 For example, for predicting DNA SOR,
the best performing descriptor by both metrics was πS(r), with
an average site AUC of 60.9% and a top-two accuracy of 27.6%,
which are both signiﬁcantly lower than ARS’s corresponding
performances of 89.8% and 80.6%. The machine learning
approach we adopt here is strikingly more accurate than
quantum chemical measures of reactivity.
As further evidence of generalizability, the model was applied
to an external test of 14 molecules reactive with GSH that were
collected from a newer version of the AMD than that used in
training (Figure 2). The model predicted SOR on this test set
with an average site AUC accuracy of 93.6%, matching the
cross-validated performance of 92.8%. The top-two external test
set performance was 64.3%, somewhat lower than the cross-
validated performance of 80.9%. The lower performance is well
explained by the high variance of the estimate, because there
are only a few molecules in the set. Moreover, the performance
of the model is still substantially better than the quantum
chemical descriptors, which are indistinguishable from zero
performance on the test molecules. Depictions of all 14 external
test set molecules with their GSH ARS and SOR are available in
the Supporting Information, alongside their most closely similar
molecule from the training set (Figure S7).
Accuracy at Identifying Reactive Molecules. Another
central goal is to accurately discriminate between reactive and
nonreactive molecules. XenoSite predicted four reactivity scores
for each molecule (MRS), each of which ranged from zero to
one, and represented the probability that the molecule is
reactive with cyanide, DNA, GSH, or protein, respectively. The
accuracies of MRS were measured by 10-fold cross-validation,
with performance quantiﬁed by the area under the ROC curve
(molecule AUC). The MRS scores were reasonably accurate in
separating reactive and nonreactive molecules (90.3%, 78.7%,
77.7%, and 79.8% for cyanide, DNA, GSH, and protein,
respectively, Figure 4). In contrast, the performances of the best
reactivity indices using traditional quantum descriptors were
much lower: 84.9% (−EHOMO for cyanide), 73.7% (max[DN(r)]
for DNA), 62.9% (πS(r) for GSH), and 65.1% (max[DN(r)])
for protein). For each nucleophilic target, MRS outperformed
all quantum chemical descriptors.
The model’s MRS scores were superior to other methods, yet
still were lower accuracy than the ARS scores. This discrepancy
was likely due to the presence of more noise in the molecule-
level data than in the atom-level data. The ascertainment bias in
the literature means that many of the negative molecules are
actually reactive. When extracting nonreactive molecules, we
assumed that molecules were not reactive to a nucleophile if
they were not reported to be reactive to that nucleophile by any
reactions in the AMD. This assumption was not solid evidence
of molecules’ nonreactivity, because many studies do not test
for reactivity. By contrast, the atom-level reactivity data were all
drawn from experiments that tested for reactivity and thus were
much less noisy with many fewer false negatives. A similar drop
from atom- to molecule-level accuracy was observed in our
previous studies with the literature derived data, including the
GSH reactivity model that was a precursor to this work.20,34 In
the future, we plan to improve the data by experimentally
testing the reactivity of “nonreactive” molecules that nonethe-
less receive high MRS. We expect that some of these false
positives will be shown to be in fact reactive and that this eﬀort
will validate the models and improve the training data.
Table 1. Quantum Chemical Reactivity Descriptors
Atom-Level Descriptors
DN(r) nucleophilic delocalizability
DE(r) electrophilic delocalizability
πS(r) self-polarizability
Molecule-Level Descriptors
ELUMO energy of the lowest unoccupied molecular orbital
EHOMO energy of the highest occupied molecular orbital
max[DN(r)] maximum atom nucleophilic delocalizability
max[DE(r)] maximum atom electrophilic delocalizability
max[πS(r)] maximum atom self-polarizability
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Molecules Missed by Standard Screening Assays.
Experimental studies with cyanide and GSH are traditional
screening tools to trap hard and soft electrophilic reactive
molecules, respectively, and thus provide potential insights on
possible reactions between the reactive molecules and bio-
logical macromolecules.16,17 Importantly, cyanide and GSH
possess only a single type of nucleophilic site, while biologically
relevant macromolecules often contain both hard and soft
nucleophiles with an array of diﬀerent structures and hence
diﬀerent chemistries. Consequently, nucleophilic trapping
assays using cyanide and GSH may not adequately reﬂect all
possible reactions observed within biological macromolecules
and thus fail to detect potentially toxic electrophiles.
We estimated how frequently molecules will react with
macromolecules (protein and DNA) but not with trapping
agents (GSH and cyanide) commonly used in experimental
screens. We calculated the probability that each molecule will
form adducts to either DNA or protein, but neither cyanide nor
GSH. The DNA probability was computed by taking the
product of its probabilities of reacting with DNA (MRSDNA)
and not reacting with cyanide (1 − MRSCN) or GSH (1 −
MRSGSH). The protein probability was computed by taking the
product of its probabilities of reacting with protein (MRSPRO)
Figure 3. Molecule reactivity scores (MRS) accurately identiﬁed reactive molecules. A number of prediction methods were compared by their
performance at identifying reactive molecules. Each nonreactive molecule is structurally similar to a reactive molecule. To measure performance, the
area under the ROC curve was calculated (molecule AUC) . For each target nucleophile, MRS outperformed all quantum chemical descriptors
tested. Right, four example molecules are visualized with their protein and GSH reactivity predictions indicated by colored shading. From top to
bottom, a TRPV1 antagonist metabolite,46 a nitroso metabolite of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (formed during cooking of
meat),47 a nicotine iminium ion metabolite (reactive with cyanide),48 and a benoxaprofen acyl glucuronide metabolite (a nonsteroidal anti-
inﬂammatory drug withdrawn due to hepatotoxicity).49 Sites of reactivity are indicated by white circles.
Figure 4. Molecule reactivity scores (MRS) predict some molecules signiﬁcantly more reactive with biological macromolecules than nucleophilic
traps used in standard screening assays. Discordant predictions between the protein and GSH models (left), and between the DNA and cyanide
models (right), are visualized. As indicated both by the colored shading (corresponding to atom reactivity scores) and by the MRS listed below, for
each molecule the biological macromolecule (protein or DNA) prediction is signiﬁcantly greater than the corresponding standard trapping agent
(GSH or cyanide) prediction. Experimentally known sites of reactivity are labeled with white circles. Upper left pair: a metabolite of 6-nitrochrysene
(MRSPRO: 0.42, MRSGSH: 0.29), an environmental pollutant.
50 Bottom left pair: N-acetoxy-sulfamethoxazole (MRSPRO: 0.51, MRSGSH: 0.38), a
metabolite that may mediate the toxicity of the antibiotic sulfamethoxazole.51 Upper right pair: a metabolite of lucidin-3-O-primeveroside (MRSDNA:
0.68, MRSCN: 0.26), a component of a food dye known to be carcinogenic in rats.
52 Bottom right pair: 7H-dibenzo(c,g)carbazole-3,4-dione
(MRSDNA: 0.64, MRSCN: 0.30), an environmental multispecies carcinogen.
53
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and not reacting with cyanide (1 − MRSCN) or GSH (1 −
MRSGSH). Next, we summed up the probabilities for all
molecules with respect to each macromolecule. These scores
are well scaled probabilities, so this sum is a valid estimate of
the total number of molecules selectively reacting with each
macromolecule and not the traditional nucleophilic traps, and
hence those that would be missed by standard screening
approaches. For the entire data set of 2803 molecules, this
approach yielded totals of 257 and 227 molecules predicted to
be reactive only with DNA and protein, respectively, and not
cyanide or GSH. This ﬁnding suggests that in our data set 9.2%
of DNA reactive molecules and 8.1% of protein reactive
molecules would be missed by standard screening assays with
cyanide and GSH. Though not the majority of molecules, this
result suggests there are shortcomings of using small-molecule
trapping agents to infer reactivity with macromolecules.
Computationally modeling could ﬁll a gap here, by identifying
these problematic molecules when screening cannot (Figure 4).
The experimental validation of speciﬁc missed reactive
molecules and these estimates is outside the scope of this
study but is planned in our future work.
■ MODEL LIMITATIONS
For predicting reactive metabolites, this study’s approach is
limited by not modeling their metabolic activation, which may
precede reactions with nucleophilic traps. Nevertheless, models
for metabolic reactions are rapidly maturing as evidenced by
our work34,35,54−56 and others,57−59 and it is conceivable that
metabolism and reactivity models could be combined for a
more biologically relevant prediction of risks poised by drugs
and other compounds. An additional caveat is that some
reactions in the database are likely missing reactive
intermediates. For example, acyl glucuronides are predicted
somewhat reactive, yet are known not to be reactive themselves.
Instead, only after acyl migration and ring opening do acyl
glucuronides form short-lived, reactive open-chain aldehyde
intermediates that can lead to covalent binding to molecules.60
There are likely other uncertainties where intermediate reactive
metabolites are not present in the database, as they may be so
reactive that they are too short-lived to be observed
experimentally. Missing intermediates is a limitation of the
data, but is both a strength and weakness of our method. On
the plus side, we implicitly model some types of rearrangements
that yield reactive species, and in doing so, expand the utility of
the model. Nevertheless, this process leads to motifs that are
not reactive themselves being predicted reactive. Therefore, we
are actually modeling a combination of intrinsic reactivity and
potential for covalent binding. A ﬁnal caveat is that the domain
of applicability of XenoSite is likely limited to drug-like
molecules. We do not expect the model to generalize well to
molecules outside of this domain, such as to inorganic
molecules. Precise assessment of the domain of applicability
is a critical question for future work. We plan to directly test
this with prospective experiments, which is much more
convincing than computational strategies for assessing the
applicability domain.
■ CONCLUSION
This study establishes that SOR modeling accurately predicts a
key driver of drug toxicity: covalent binding to DNA and
protein. The XenoSite reactivity model identiﬁes SOR within
reactive molecules with AUC performances of 96.6%, 89.8%,
92.8%, and 94.4%, for cyanide, DNA, GSH, and protein,
respectively. Compared to building separate models, collec-
tively modeling reactivity for all four nucleophilic targets
enabled knowledge transfer between tasks, improving SOR
predictions for cyanide and protein. For cyanide, DNA, GSH,
and protein, the model separates reactive and nonreactive
molecules with, respectively, 90.3%, 78.7%, 77.7%, and 79.8%
AUC. These predictions of molecular reactivity can highlight
potentially toxic molecules that might be missed in the early
stages of drug development. Ultimately, to accurately predict
reactive metabolites, both metabolism and reactivity must be
modeled. While there has been signiﬁcant progress on
metabolism modeling,34,35,54−59,61 reactivity modeling has
lagged far behind. By accurately modeling reactivity across a
broad range of chemical space for biologically relevant
macromolecules, such as DNA and protein, this study
contributes a fundamental component of an integrative model
of metabolism and reactivity.
■ METHODS
Site of Reactivity Training Data.We assembled a training
data set from the December 2014 release of the literature-
derived Accelrys Metabolite Database (AMD). From 2489 total
reactions, molecules were extracted based on reported reactions
with cyanide, DNA, GSH, or protein. For each target
nucleophile, the reactive atom(s) within each reactive molecule
were marked based on the structures of the starting and
product molecules, using an automated algorithm constructed
using the RDKit python library.62 Topologically equivalent
atoms were found using the Pybel python library, and atoms
equivalent to reactive atoms were themselves labeled as
reactive.63 The ﬁnal data set included, in total, 1364
electrophilic molecules with their reactive atoms and SORs
marked. This data set was composed of 51, 145, 1059, and 120
molecules known to be reactive with cyanide, DNA, GSH, or
protein, respectively. For each of the four reactive nucleophilic
targets, the atoms across the whole data set were labeled as
reactive or nonreactive. Some atoms were marked reactive with
more than one nucleophile.
Metabolically related but nonreactive molecules were
extracted from the reaction network of each reactive molecule.
Metabolic sibling and parent molecules were extracted from
this network, while excluding molecules themselves known to
be reactive. We also included 63 naturally occurring64 and
known nonreactive65 epoxides as nonreactive molecules. While
epoxides are generally quite reactive, they can be stable in
certain cases; however, a shortcoming of our previous method
for predicting GSH reactivity was that it predicted all epoxides
reactive.20 These molecules were added to mitigate this
shortcoming.
A total of 1439 molecules were labeled nonreactive, with 103,
248, 1269, and 255 labeled nonreactive to cyanide, DNA, GSH,
and protein, respectively. At the molecule-level, for each of the
four reactive nucleophilic targets, molecules across the entire
data set were labeled as reactive or nonreactive. Some
molecules were marked reactive or nonreactive with more
than one nucleophile.
To enable replication of our work, we included all AMD
molecule registry numbers in the Supporting Information, in
addition to the SMILES strings of the nonreactive epoxides.
Unfortunately, the AMD license precluded us from dissem-
inating the rest of the molecule structures themselves.
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External Site of Reactivity Test Data. After the training
data were assembled, a new version of the AMD was released
(June 2015) with several new reactions, which was used as an
external data set. We ﬁltered out all molecules already labeled
as reactive in the training data. This process left only 14 new
molecules that reacted with GSH and no new molecules
reacting with cyanide, DNA, or protein. These 14 molecules
were completely withheld from model training and optimiza-
tion decisions, and were only tested with the ﬁnal model.
Quantum Chemical Reactivity Indices. Several quantum
chemical descriptors were calculated from self-consistent ﬁeld
computations with MOPAC, a quantum chemistry package,
using the semiempirical method PM7 and the COSMO implicit
solvent model.66,67 These included descriptors that have been
previously proposed as reactivity indices, on both the atom- and
molecule-level (Table 1).68−70 Atom-level descriptors include
the nucleophilic (DN(r)) and electrophilic (DE(r)) delocaliz-
abilities, which are also known as fukui reactivity indices, as well
as self-polarizability (πS(r)). The maximum of each of these
(max[DN(r)], max[DE(r)], and max[πS(r)]) were used as
molecule descriptors, which also included the energies of the
lowest unoccupied and highest occupied molecular orbitals
(ELUMO and EHOMO). The performances of the ﬁnal reactivity
modelwhich only used topological descriptorswere
compared to those of the quantum chemical indices.
Topological Descriptors. The reactivity model used 15
molecule-level and 194 atom-level topological descriptors, each
of which describes a chemical property. An in-house python
script calculated these descriptors from the structure of each
molecule. This script derives these descriptors from several
sources, such as each molecule’s connectivity distance matrix,
periodic table properties, or motif patterns deﬁned by Pybel.63
The majority of our topological descriptors have been shown to
be useful for the XenoSite metabolism, reactivity, and
epoxidation models.20,34,35 In this study, we used an expanded
set of topological descriptors, which slightly improved perform-
ance in comparison to the previous set of topological
descriptors (Figure S1). The full list of descriptors is available
in the Supporting Information (Tables S1 and S2), as well as a
list of new topological descriptors added for this project.
Combined Atom- and Molecule-Level Reactivity
Model. We collectively modeled reactivity to cyanide, DNA,
GSH, and protein at both the atom- and molecule-level by
building a deep neural network using an in-house machine
learning python library. The architecture included a molecule
layer, an input layer, two hidden layers, and two output layers
(Figure 5). The atom output layer computed atom-level SOR
predictions against each nucleophile, while the molecule output
layer computed molecule reactivity scores (MRS) for each
nucleophile. The corresponding scores predicted the chances
that a test molecule is reactive against that nucleophile.
We trained this network in two stages. First, the atom-level
network was trained to produce atom reactivity scores (ARS).
For this process, each atom was considered a possible SOR. A
numerical vector was associated with each atom, which
contained all of the descriptors for that atom. A binary target
vector indicated if each atom was a SOR for each of the
nucleophilic targets. For molecules of unknown reactivity
against each nucleophilic target, the appropriate values were
empty, neither one nor zero. Using gradient descent on the
cross-entropy error, the weights of the network were trained
such that SOR scored higher ARS than other atoms. Four ARS
were produced for each atom, each ranging from zero to one,
and representing the probability that the atom will be reactive
with cyanide, DNA, GSH, or protein.
Second, the molecule-output nodes were trained to compute
MRS. For this stage, each molecule was considered possibly
reactive, and a numerical vector of descriptors was associated
with each molecule. Descriptors included all molecule-level
descriptors, as well as the top ﬁve ARS for each of the four
nucleophilic targets, corresponding to the scores of the ﬁve
atoms predicted within a molecule to be the most reactive to
each nucleophile. For each molecule, a binary target vector
(with unknown components empty) indicated if the molecule
was reactive to each of the nucleophilic targets. For each
nucleophile, a logistic regressor found a scoring function that
gave reactive molecules high MRS and nonreactive molecules
low MRS, ranging from zero to one.
Figure 5. The structure of the XenoSite reactivity model. This diagram
illustrates how information ﬂowed through the model, which consisted
of one input layer, two hidden layers, and two output layers. By
simultaneously modeling all types of reactivity, the model was able to
transfer knowledge between related tasks, thereby improving perform-
ance substantially over independent models. The model computed
atom-level predictions for reactivity to each of four nucleophilic
targets: cyanide (ARSCN), DNA (ARSDNA), GSH (ARSGSH), and
protein (ARSPRO), collectively referred to as atom reactivity scores
(ARS). Additionally, the model computed molecule reactivity scores
(MRS): MRSCN, MRSDNA, MRSGSH, and MRSPRO, which predicted the
chances of a molecule’s reactivity to each of the four nucleophilic
targets, respectively. From the structure of an input model χ, 15
molecule-level and 194 atom-level descriptors were calculated. Some
chemically related descriptors, such as neighbor atom identities, were
grouped in the ﬁrst hidden layer (with 30 nodes). Grouped and
ungrouped nodes were inputted into the second hidden layer (with 17
nodes), which outputted four atom-level scores. Finally, for each of the
four nucleophilic targets, the respective MRS was computed from the
top ﬁve ARS for each of the four nucleophilic targets, corresponding to
the scores of the ﬁve atoms predicted within a molecule to be the most
reactive to each nucleophile, as well as all molecule-level descriptors.
The diagram is condensed and displays one representative molecule
input node, ﬁve atom input nodes, and two nodes for each hidden
layer. The molecule input node is a chemical structure; all other nodes
are vectors of real numbers computed from nodes or layers from which
there are incoming connections.
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